首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed
【2h】

Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed

机译:Intersectin-1s肺表达的调制诱导小鼠肺血管床的闭塞性重塑和严重多形性动脉病。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Murine models of pulmonary arterial hypertension (PAH) that recapitulate the plexiform and obliterative arteriopathy seen in PAH patients and help in defining the molecular mechanisms involved are missing. Herein, we investigated whether intersectin-1s (ITSN) deficiency and prolonged lung expression of an ITSN fragment with endothelial cell (EC) proliferative potential (EHITSN), present in the lungs of PAH animal models and human patients, induce formation of plexiform/obliterative lesions and defined the molecular mechanisms involved. ITSN-deficient mice (knockout/heterozygous and knockdown) were subjected to targeted lung delivery of EHITSN via liposomes for 20 days. Immunohistochemistry and histological and morphometric analyses revealed a twofold increase in proliferative ECs and a 1.35-fold increase in proliferative α-smooth muscle actin–positive cells in the lungs of ITSN-deficient mice, transduced with the EHITSN relative to wild-type littermates. Treated mice developed severe medial wall hypertrophy, intima proliferation, and various forms of obliterative and plexiform-like lesions in pulmonary arteries, similar to PAH patients. Hemodynamic measurements indicated modest increases in the right ventricular systolic pressure and right ventricle hypertrophy. Transcriptional and protein assays of lung tissue indicated p38MAPK-dependent activation of Elk-1 transcription factor and increased expression of c-Fos gene. This unique murine model of PAH-like plexiform/obliterative arteriopathy induced via a two-hit pathophysiological mechanism without hypoxia provides novel druggable targets to ameliorate and, perhaps, reverse the EC plexiform phenotype in severe human PAH.
机译:缺少了肺动脉高压(PAH)的鼠模型,该模型概括了PAH患者所见的丛状和闭塞性动脉病,并有助于确定所涉及的分子机制。本文中,我们调查了PAH动物模型和人类患者的肺中是否存在intersectin-1s(ITSN)缺陷和ITSN片段与内皮细胞(EC)增殖潜能(EHITSN)的肺表达延长,是否诱导丛状/闭塞性形成病变并定义了涉及的分子机制。缺乏ITSN的小鼠(敲除/杂合和敲除)经过脂质体靶向EHITSN肺部递送20天。免疫组织化学,组织学和形态计量学分析显示,与野生型同窝仔猪相比,EHITSN转导的ITSN缺陷小鼠肺中增殖性EC增加了两倍,增殖性α平滑肌肌动蛋白阳性细胞增加了1.35倍。与PAH患者相似,经治疗的小鼠在肺动脉中出现严重的内壁肥大,内膜增生以及各种形式的闭塞性和丛状样病变。血液动力学测量表明右心室收缩压和右心室肥大适度增加。肺组织的转录和蛋白分析表明,p38 MAPK 依赖于Elk-1转录因子的激活和c-Fos基因表达的增加。通过两次击中的病理生理机制而无缺氧诱导的PAH样丛状/闭塞性动脉病这种独特的鼠模型提供了新的可药物化靶点,以减轻甚至逆转严重人PAH中的EC丛状表型。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号